We observed markedly elevated cytokine responses in COVID-19 patients upon Toll-like receptor 4 (TLR4) activation by lipopolysaccharide (LPS) and TLR7/8 activation by R848 (Figures 1H and 1I). The gene discussed is TLR7; the disease is COVID-19.